Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/39774
Title: | Gender differences in risk factor management and pharmacological treatment among CHD patients: Belgian results of the EUROASPIRE IV and EUROASPIRE V surveys | Authors: | Vynckier, Pieter De Sutter, Johan De Pauw, Michel Vandekerckhove, Hans De Backer, Guy Vervaet, Pieter Deweerdt, Nancy DENDALE, Paul Persu, Alexandre JANSSEN, Arne Chenu, Patrick Kotseva, Kornelia Gevaert, Sofie De Bacquer, Dirk De Smedt, Delphine EUROASPIRE IV Investigators Grp EUROASPIRE V Investigators Grp |
Issue Date: | 2023 | Publisher: | TAYLOR & FRANCIS LTD | Source: | ACTA CARDIOLOGICA, 78 (5) , p. 607-613 | Abstract: | AimsThe aim of this study was to provide an up-to-date overview of gender differences or similarities in risk factor control and medical management in the Belgian CHD population.MethodsAll analyses are based on the ESC EORP EUROASPIRE IV and EUROASPIRE V (European Survey Of Cardiovascular Disease Prevention And Diabetes) surveys. Patients between 18 and 80 years old, hospitalised for a first or recurrent coronary event, were included in the survey.ResultsData were available for 10,519 patients, of which 23.9% were women. Women had a worse risk factor profile compared to men. Women were more physical inactive (OR = 1.31, 95% CI = 1.19-1.44), had a higher prevalence of obesity (OR = 1.37, 95% CI = 1.25-1.50) and had a worse LDL-C control (OR = 1.52, 95% CI = 1.36-1.70). Moreover, women were less likely to use ACE-I/ARBs (OR = 0.84, 95% CI = 0.76-0.94) and statins (OR = 0.79, 95% CI = 0.70-0.90). In addition, little gender differences were found in patients' risk factor awareness, except on cholesterol awareness. Women were more aware about their total cholesterol levels (OR = 1.37, 95% CI = 1.21-1.56).ConclusionDespite little to no gender differences in the management of CHD patients, women still have a worse risk factor profile, both in Belgian and in other European high-income countries. | Notes: | Vynckier, P (corresponding author), Univ Ghent, Corneel Heymanslaan 10, B-9000 Ghent, Belgium. Pieter.Vynckier@Ugent.be |
Keywords: | EUROASPIRE;risk factors;pharmacological treatment;coronary heart disease;awareness;gender | Document URI: | http://hdl.handle.net/1942/39774 | ISSN: | 0001-5385 | e-ISSN: | 1784-973X | DOI: | 10.1080/00015385.2023.2169439 | ISI #: | 000934466900001 | Category: | A1 | Type: | Journal Contribution |
Appears in Collections: | Research publications |
Show full item record
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.